SEI Investments
BBIO icon

SEI Investments’s BridgeBio Pharma BBIO Stock Holding History

SEI Investments’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4M Sell
247,678
-40,397
-14% -$2.83M 0.02% 846
2026
Q1 		$21.4M Buy
288,075
+63,209
+28% +$4.58M 0.02% 762
2025
Q4 		$17.2M Buy
224,866
+108,268
+93% +$7.11M 0.02% 814
2025
Q3 		$6.06M Buy
116,598
+55,720
+92% +$2.72M 0.01% 1226
2025
Q2 		$2.63M Buy
60,878
+16,695
+38% +$607K ﹤0.01% 1543
2025
Q1 		$1.53M Buy
44,183
+24,630
+126% +$831K ﹤0.01% 1731
2024
Q4 		$537K Buy
19,553
+1,131
+6% +$29.2K ﹤0.01% 2166
2024
Q3 		$469K Sell
18,422
-5,245
-22% -$138K ﹤0.01% 2211
2024
Q2 		$600K Sell
23,667
-26,111
-52% -$714K ﹤0.01% 2095
2024
Q1 		$1.54M Sell
49,778
-6,280
-11% -$214K ﹤0.01% 1727
2023
Q4 		$2.26M Buy
56,058
+19,405
+53% +$583K ﹤0.01% 1543
2023
Q3 		$967K Sell
36,653
-6,623
-15% -$188K ﹤0.01% 1895
2023
Q2 		$744K Sell
43,276
-7,165
-14% -$108K ﹤0.01% 1988
2023
Q1 		$836K Buy
+50,441
New +$588K ﹤0.01% 1938
2021
Q3 		– Sell
-58,707
Closed -$3.58M – 2555
2021
Q2 		$3.58M Sell
58,707
-3,850
-6% -$220K 0.01% 1243
2021
Q1 		$3.85M Buy
62,557
+35,791
+134% +$2.34M 0.01% 1160
2020
Q4 		$1.9M Buy
+26,766
New +$1.29M ﹤0.01% 1419

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

SEI Investments's BBIO Position: Q2 2026 in Review

SEI Investments reduced its BridgeBio Pharma (BBIO) stake by 14% in Q2 2026, selling an estimated $2.83M and leaving 247,678 shares worth $18.4M. The position accounts for 0.02% of the portfolio, ranked #846.

SEI Investments first reported a position in BBIO in Q4 2020 and has held it in 17 quarters since. The position peaked at $21.4M in Q1 2026. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • SEI Investments held 247,678 shares of BridgeBio Pharma worth $18.4M as of Q2 2026.
  • SEI Investments sold 40,397 BridgeBio Pharma shares in Q2 2026, an estimated $2.83M.
  • BridgeBio Pharma made up 0.02% of SEI Investments's portfolio in Q2 2026, its #846 holding.
  • SEI Investments first reported a position in BridgeBio Pharma in Q4 2020 and has held it in 17 quarters since.
  • SEI Investments's BridgeBio Pharma position peaked at $21.4M in Q1 2026.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.